HomeresearchtDCS when implanted Parkinson-Pacemaker (DBS) is present

tDCS when implanted Parkinson-Pacemaker (DBS) is present

-

tDCS in patients with implanted Parkinson’s brain pacemakers (DBS)

As a general rule: tDCS in patients with an implanted Deep Brain Stimulator (DBS) is not automatically prohibited, but there is a relevant safety risk, so it is only performed under clear precautionary measures and usually within a research setting.

 

DBS typically consists of three components:

  • Intracerebral electrodes (e.g., in the subthalamic nucleus or globus pallidus internus)
  • Extension leads running subcutaneously along the neck/thorax
  • Impulse generator (similar to a heart pacemaker), usually implanted infraclavicularly

These metal structures can theoretically interact with externally applied electrical fields.

Potential Risks

  • Induction of currents along the DBS leads
    tDCS can conduct parasitic currents into deeper brain structures via the cables.
  • Overstimulation or malfunction of the DBS
    Theoretically possible through electromagnetic interaction.
  • Uncontrolled current density at the electrode tip in the brain
  • Heating of the electrodes
    Especially during longer stimulation periods.

These risks are theoretically plausible, but clinically rarely systematically investigated.

 

Current State of Research

There are a few small studies in which tDCS was performed on Parkinson’s patients with DBS, typically using:

  • Anodal stimulation over M1 or DLPFC
  • 1–2 mA
  • 20 minutes

In these small series, no serious side effects were reported. Nevertheless, virtually all publications emphasize:

  • Performance only under neurological supervision
  • Device check before and after stimulation
  • Frequent temporary deactivation of the DBS

The evidence base is very small.

 

Practical Safety Rules (if performed at all)

If tDCS is being considered:

  • Turn off the DBS during stimulation if possible
  • Place electrodes far away from the generator
    (no current path across the thorax/neck)
  • No electrodes near the DBS cables
    (e.g., avoid Fp-mastoid montages)
  • Low intensity
    • 1.0–1.5 mA
  • Short duration
    • 10–20 minutes
  • Monitor the patient

 

Clinical Summary

With an implanted Parkinson’s brain pacemaker, tDCS is fundamentally possible but potentially risky and therefore not standard practice.

Many centers consider it a relative contraindication, especially outside of clinical trials.

 

Practical Note from a Neuromodulatory Perspective

For Parkinson’s patients with DBS implants, one would usually opt for other non-invasive procedures:

  • TPS (Transcranial Pulse Stimulation)
  • taVNS
  • CES
  • Peripheral Neuromodulation

These do not generate an electrical field in the brain and are therefore significantly less problematic regarding implants.

 

OK, Petros also sent an answer today 15-3-2026

There are generally no absolute contraindications for using either transcranial pulse stimulation (TPS) or transcranial direct current stimulation (tDCS) in patients with a ventriculo-peritoneal shunt system, including programmable valves such as proGAV 2.0, provided certain precautions are respected.
The proGAV® 2.0 is a programmable differential-pressure hydrocephalus valve with a gravitational unit designed to regulate CSF drainage depending on body position and pressure conditions.  
Key considerations with a VP shunt (proGAV 2.0)
1. Location of stimulation
•Avoid direct electrode or TPS focal targeting directly over the valve housing (retroauricular region).
•Stimulation can usually be performed safely on cortical regions away from the valve reservoir or catheter path.
2. Mechanical safety
•tDCS uses very low currents (typically ≤2–4 mA) and is considered safe in clinical research with minimal adverse effects.  
•These currents do not affect silicone shunt catheters or CSF flow.
3. Magnetic / device interaction
•The proGAV 2.0 has an “Active-Lock” mechanism designed to prevent accidental valve adjustment from external magnetic fields.  
•Therefore, low-energy neuromodulation such as tDCS or TPS does not typically alter the valve setting.
4. Clinical precautions
•Verify valve setting before and after treatment (good clinical practice).
•Avoid strong local pressure over the burr-hole reservoir.
•Be aware of the catheter trajectory from ventricle → retroauricular valve → peritoneum.
Practical clinical approach
•Safe montages usually involve frontal, motor, parietal or cerebellar regions away from the valve.
•Keep stimulation standard neuromodulation parameters.
•If the valve is retroauricular, avoid electrode placement directly on the valve pocket.
Summary
A VP shunt such as proGAV 2.0 is not considered a contraindication for non-invasive neuromodulation (tDCS or TPS). Treatment can generally be performed safely with appropriate attention to valve location, catheter path, and routine clinical monitoring.

here he sites a study without sending the primary publication link

A 2024 case report describing tDCS in a patient with severe brain injury, a ventriculoperitoneal shunt, and titanium mesh cranioplasty. The authors used MRI-based electric-field modeling to optimize electrode placement, reported no device-related complication, and described substantial clinical improvement. This is probably the most directly relevant published paper for your question, but it is still only one case report, so it supports feasibility more than it proves broad safety. 

More broadly, modern tDCS safety reviews and guidelines say there are no absolute contraindications to tDCS in general practice, although prior head surgery, altered anatomy, and implanted metallic/electrical devices require extra planning because they can change current distribution. A 2021 safety review reported no severe complications in adults or children when standard parameters up to 4 mA for up to 60 minutes/day were used, and the 2023 clinical practice guideline similarly states that there are no absolute contraindications while emphasizing caution with brain injury, surgery, and implants.

Google CENSORSHIP!

Google censors my homepage quite a bit, sometimes I am not even able to find my articles on Google. So please sign up for the newsletter and share it with friends or via Facebook and use the search function on my website. Follow me on Twitter, where I also announce important articles.